NYSE:HCC

Warrior Met Coal Stock News

etoro logo Buy HCC
*Your capital is at risk
$105.88
-4.40 (-3.99%)
At Close: Jun 03, 2026
Thermal coal may retire for good in the U.S., but metallurgical coal could see “healthy” growth, says analyst.
MORRISTOWN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatoh
Warrior Met Coal's strong margins and strategic location contribute to its resilience, with only a 12% stock price decline this year compared to peers' 30-40% drop. Q1 2025 results showed a weak perfo
Warrior Met Coal, Inc. (NYSE:HCC ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Brian Chopin - Chief Accounting Officer and Controller Walter Scheller - Chief Execut
Warrior Met Coal (HCC) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $2.63 per share a year ago.

Warrior Reports First Quarter 2025 Results

04:05pm, Wednesday, 30'th Apr 2025
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE: HCC) (“Warrior” or the “Company”) today announced results for the first quarter of 2025. Warrior is the leading dedicated U.S.-b

Warrior Announces Regular Quarterly Cash Dividend

04:15pm, Wednesday, 23'rd Apr 2025
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today announced that its board of directors has approved a regular quarterly cash dividend of $
Warrior Met Coal (HCC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (“Warrior” or NYSE: HCC) today announced that it will hold its first quarter 2025 investor conference call at 4:30 p.m. ET on Wednesday, Ap
Warrior Met Coal, Inc. is well-positioned to weather current low coal prices due to its low-cost production and strong balance sheet, with Blue Creek set to enhance margins and production. Despite cur
• Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC) • Announced Agreement with Roche to Support Advance
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today launched a new webpage dedicated to the Blue Creek project. Warrior will use this new web
The EC approves BMY's combination of Opdivo and Yervoy for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma.
HOUSTON, March 05, 2025 (GLOBE NEWSWIRE) -- Tokio Marine HCC, based in Houston, Texas, today announced that Mike Schell will retire from his role as President of the company on March 31, 2025. Barry C
BROOKWOOD, Ala.--(BUSINESS WIRE)--Warrior Met Coal, Inc. (NYSE:HCC) (“Warrior” or the “Company”) today provided several positive operational and financial updates regarding its progress toward
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE